222. 一次性ネフローゼ症候群 Primary nephrotic syndrome Clinical trials / Disease details

臨床試験数 : 285 / 薬物数 : 285 - (DrugBank : 108) / 標的遺伝子数 : 62 - 標的パスウェイ数 : 191

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03095118 (ClinicalTrials.gov)	September 7, 2017	20/3/2017	Daratumumab in Treatment of PGNMID and C3 GN	Single-center Phase 2 Open-label Trial Evaluating Efficacy and Safety of Daratumumabin Treatment of ...	Membranoproliferative Glomerulonephritis	Drug: Daratumumab	Fernando Fervenza	NULL	Active, not recruiting	18 Years	N/A	All	10	Phase 2	United States